ALDOA Gene Glycogen Storage Disease Type 12 Genetic Test
Components:
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test type: Metabolic Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information:
Clinical History of Patient who is going for ALDOA Gene Glycogen storage disease type 12 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Glycogen storage disease type 12.
Test Details:
The ALDOA gene is responsible for producing the aldolase A enzyme, which plays a crucial role in breaking down glucose for energy production in cells. Mutations in the ALDOA gene can lead to a condition known as glycogen storage disease type 12 (GSD12). Glycogen storage diseases are a group of genetic disorders characterized by abnormal storage or metabolism of glycogen, a form of glucose stored in the liver and muscles. In the case of GSD12, mutations in the ALDOA gene impair the function of the aldolase A enzyme, leading to a buildup of glycogen in tissues and organs.
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, providing a comprehensive evaluation of an individual’s genetic makeup. In the context of GSD12, NGS genetic testing can be used to identify mutations in the ALDOA gene, confirming the diagnosis of the condition. By detecting mutations in the ALDOA gene, NGS genetic testing can help determine the underlying cause of glycogen storage disease type 12. This information can be useful for genetic counseling, family planning, and potentially guiding treatment strategies. Additionally, NGS testing can also be beneficial for early diagnosis, allowing for prompt intervention and management of the condition.
Test Name | ALDOA Gene Glycogen storage disease type 12 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for ALDOA Gene Glycogen storage disease type 12 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glycogen storage disease type 12 |
Test Details |
The ALDOA gene is responsible for producing the aldolase A enzyme, which plays a crucial role in breaking down glucose for energy production in cells. Mutations in the ALDOA gene can lead to a condition known as glycogen storage disease type 12 (GSD12). Glycogen storage diseases are a group of genetic disorders characterized by abnormal storage or metabolism of glycogen, a form of glucose stored in the liver and muscles. In the case of GSD12, mutations in the ALDOA gene impair the function of the aldolase A enzyme, leading to a buildup of glycogen in tissues and organs. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, providing a comprehensive evaluation of an individual’s genetic makeup. In the context of GSD12, NGS genetic testing can be used to identify mutations in the ALDOA gene, confirming the diagnosis of the condition. By detecting mutations in the ALDOA gene, NGS genetic testing can help determine the underlying cause of glycogen storage disease type 12. This information can be useful for genetic counseling, family planning, and potentially guiding treatment strategies. Additionally, NGS testing can also be beneficial for early diagnosis, allowing for prompt intervention and management of the condition. |